Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daichi Inoue

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Leukemia|July 18, 2023
SETBP1 is dispensable for normal and malignant hematopoiesisAtsushi Tanaka, Koutarou Nishimura, Wataru Saika, et al.
Nature Communications|July 18, 2018
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesisShuhei Asada, Susumu Goyama, Daichi Inoue, et al.
The Journal of Experimental Medicine|April 13, 2018
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformationReina Nagase, Daichi Inoue, Alessandro Pastore, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|December 16, 2014
The molecular basis of myeloid malignanciesToshio Kitamura, Daichi Inoue, Naoko Okochi-Watanabe, et al.
Blood|May 15, 2014
Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cellsFumio Nakahara, Jiro Kitaura, Tomoyuki Uchida, et al.
Cancer Cell|February 26, 2019
Targeting an RNA-Binding Protein Network in Acute Myeloid LeukemiaEric Wang, Sydney X Lu, Alessandro Pastore, et al.
Leukemia|March 21, 2018
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignanciesDaichi Inoue, Takeshi Fujino, Paul Sheridan, et al.
The Journal of Clinical Investigation|November 13, 2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsDaichi Inoue, Jiro Kitaura, Katsuhiro Togami, et al.
Nature Communications|March 24, 2021
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathwayTakeshi Fujino, Susumu Goyama, Yuki Sugiura, et al.
Blood|January 8, 2025
Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineagesYumi Aoyama, Hiromi Yamazaki, Koutarou Nishimura, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Leukemia|July 18, 2023
SETBP1 is dispensable for normal and malignant hematopoiesisAtsushi Tanaka, Koutarou Nishimura, Wataru Saika, et al.
Nature Communications|July 18, 2018
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesisShuhei Asada, Susumu Goyama, Daichi Inoue, et al.
The Journal of Experimental Medicine|April 13, 2018
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformationReina Nagase, Daichi Inoue, Alessandro Pastore, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|December 16, 2014
The molecular basis of myeloid malignanciesToshio Kitamura, Daichi Inoue, Naoko Okochi-Watanabe, et al.
Blood|May 15, 2014
Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cellsFumio Nakahara, Jiro Kitaura, Tomoyuki Uchida, et al.
Cancer Cell|February 26, 2019
Targeting an RNA-Binding Protein Network in Acute Myeloid LeukemiaEric Wang, Sydney X Lu, Alessandro Pastore, et al.
Leukemia|March 21, 2018
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignanciesDaichi Inoue, Takeshi Fujino, Paul Sheridan, et al.
The Journal of Clinical Investigation|November 13, 2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutationsDaichi Inoue, Jiro Kitaura, Katsuhiro Togami, et al.
Nature Communications|March 24, 2021
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathwayTakeshi Fujino, Susumu Goyama, Yuki Sugiura, et al.
Blood|January 8, 2025
Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineagesYumi Aoyama, Hiromi Yamazaki, Koutarou Nishimura, et al.
Pageof 9